BACKGROUND: People who suffer from paralysis have difficulties participating in society. Particularly burdensome is the locked-in syndrome (LIS). LIS patients are not able to move and speak but are cognitively healthy. They rely on assistive technology to interact with the world and may benefit from neurotechnological advances. Optimal research and design of such aids requires a well-defined target population. However, the LIS population is poorly characterized and the number of patients in this condition is unknown. OBJECTIVE: Here we estimated and described the LIS patient population in the Netherlands to define the target population for assistive (neuro)technology. METHODS: We asked physicians in the Netherlands if they had patients suffering from severe paralysis and communication problems in their files. Physicians responding affirmatively were asked to fill out a questionnaire on the patients' status. RESULTS: We sent out 9570 letters to general practitioners (GPs), who reported 83 patients. After first screening, the GPs of 46 patients received the questionnaire. Based on the responses, 26 patients were classified as having LIS. Extrapolation of these numbers resulted in a prevalence of 0.73 patients per 100 000 inhabitants. Notable results from the questionnaire were the percentage of patients with neuromuscular disease (>50%) and living at home (>70%). CONCLUSIONS: We revealed an etiologically diverse group of LIS patients. The functioning and needs of these patients were, however, similar and many relied on assistive technology. By characterizing the LIS population, our study may contribute to optimal development of assistive (neuro)technology.
BACKGROUND: People who suffer from paralysis have difficulties participating in society. Particularly burdensome is the locked-in syndrome (LIS). LIS patients are not able to move and speak but are cognitively healthy. They rely on assistive technology to interact with the world and may benefit from neurotechnological advances. Optimal research and design of such aids requires a well-defined target population. However, the LIS population is poorly characterized and the number of patients in this condition is unknown. OBJECTIVE: Here we estimated and described the LIS patient population in the Netherlands to define the target population for assistive (neuro)technology. METHODS: We asked physicians in the Netherlands if they had patients suffering from severe paralysis and communication problems in their files. Physicians responding affirmatively were asked to fill out a questionnaire on the patients' status. RESULTS: We sent out 9570 letters to general practitioners (GPs), who reported 83 patients. After first screening, the GPs of 46 patients received the questionnaire. Based on the responses, 26 patients were classified as having LIS. Extrapolation of these numbers resulted in a prevalence of 0.73 patients per 100 000 inhabitants. Notable results from the questionnaire were the percentage of patients with neuromuscular disease (>50%) and living at home (>70%). CONCLUSIONS: We revealed an etiologically diverse group of LIS patients. The functioning and needs of these patients were, however, similar and many relied on assistive technology. By characterizing the LIS population, our study may contribute to optimal development of assistive (neuro)technology.
Authors: Leigh R Hochberg; Mijail D Serruya; Gerhard M Friehs; Jon A Mukand; Maryam Saleh; Abraham H Caplan; Almut Branner; David Chen; Richard D Penn; John P Donoghue Journal: Nature Date: 2006-07-13 Impact factor: 49.962
Authors: Philip R Kennedy; M Todd Kirby; Melody M Moore; Brandon King; Adon Mallory Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2004-09 Impact factor: 3.802
Authors: José León-Carrión; Philippe van Eeckhout; María Del Rosario Domínguez-Morales; Francisco Javier Pérez-Santamaría Journal: Brain Inj Date: 2002-07 Impact factor: 2.311
Authors: Jane E Huggins; Christoph Guger; Erik Aarnoutse; Brendan Allison; Charles W Anderson; Steven Bedrick; Walter Besio; Ricardo Chavarriaga; Jennifer L Collinger; An H Do; Christian Herff; Matthias Hohmann; Michelle Kinsella; Kyuhwa Lee; Fabien Lotte; Gernot Müller-Putz; Anton Nijholt; Elmar Pels; Betts Peters; Felix Putze; Rüdiger Rupp; Gerwin Schalk; Stephanie Scott; Michael Tangermann; Paul Tubig; Thorsten Zander Journal: Brain Comput Interfaces (Abingdon) Date: 2019-12-10
Authors: Zachary V Freudenburg; Mariana P Branco; Sacha Leinders; Benny H van der Vijgh; Elmar G M Pels; Timothy Denison; Leonard H van den Berg; Kai J Miller; Erik J Aarnoutse; Nick F Ramsey; Mariska J Vansteensel Journal: Front Neurosci Date: 2019-10-16 Impact factor: 4.677
Authors: Elmar G M Pels; Erik J Aarnoutse; Sacha Leinders; Zac V Freudenburg; Mariana P Branco; Benny H van der Vijgh; Tom J Snijders; Timothy Denison; Mariska J Vansteensel; Nick F Ramsey Journal: Clin Neurophysiol Date: 2019-07-27 Impact factor: 3.708
Authors: Mariana P Branco; Elmar G M Pels; Ruben H Sars; Erik J Aarnoutse; Nick F Ramsey; Mariska J Vansteensel; Femke Nijboer Journal: Neurorehabil Neural Repair Date: 2021-02-03 Impact factor: 3.919